Literature DB >> 26616280

Oxidative stress-responsive transcription factor NRF2 is not indispensable for the human hepatic Flavin-containing monooxygenase-3 (FMO3) gene expression in HepG2 cells.

Swetha Rudraiah1, Xinsheng Gu2, Ronald N Hines3, José E Manautou4.   

Abstract

The flavin-containing monooxygenases (FMOs) are important for the oxidation of a variety of endogenous compounds and xenobiotics. The hepatic expression of FMO3 is highly variable and until recently, it was thought to be uninducible. In this study, human FMO3 gene regulation by the oxidative stress transcription factor, nuclear factor (erythroid-derived 2)-like 2 (NRF2) was examined. Constitutive FMO3 gene expression is repressed in HepG2 cells, thus this cell can be a good model for FMO3 gene regulation studies. Over-expression of NRF2 in HepG2 cells increased NRF2 target gene expression, heme oxygenase-1 (HMOX1) and NAD(P)H: quinone oxidoreductase-1 (NQO1), but did not alter FMO3 gene expression. Co-transfection studies with NRF2 or its cytosolic regulatory protein, Kelch-like ECH-associated protein 1 (KEAP1), expression vectors, along with FMO3 promoter luciferase reporter constructs of various lengths (5kb or 6kb), did not change FMO3 reporter gene activity significantly. Furthermore, treatment with tert-butyl hydroperoxide (tBHP) and tert-butyl hydroquinone (tBHQ) did not alter FMO3 reporter construct activity. In summary, in vitro results suggest that the transcriptional regulation of FMO3 might not involve the NRF2-KEAP1 regulatory pathway.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Flavin-containing monoxygenase-3; KEAP1; NRF2; Oxidative stress; Tert-butyl hydroperoxide; Tert-butyl hydroquinone

Mesh:

Substances:

Year:  2015        PMID: 26616280      PMCID: PMC4695222          DOI: 10.1016/j.tiv.2015.11.016

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  21 in total

1.  Bach1 inhibits oxidative stress-induced cellular senescence by impeding p53 function on chromatin.

Authors:  Yoshihiro Dohi; Tsuyoshi Ikura; Yutaka Hoshikawa; Yasutake Katoh; Kazushige Ota; Ayako Nakanome; Akihiko Muto; Shinji Omura; Tsutomu Ohta; Akihiro Ito; Minoru Yoshida; Tetsuo Noda; Kazuhiko Igarashi
Journal:  Nat Struct Mol Biol       Date:  2008-11-16       Impact factor: 15.369

2.  Nuclear factor-E2-related factor 2 expression in liver is critical for induction of NAD(P)H:quinone oxidoreductase 1 during cholestasis.

Authors:  Lauren M Aleksunes; Angela L Slitt; Jonathan M Maher; Matthew Z Dieter; Tamara R Knight; Michael Goedken; Nathan J Cherrington; Jefferson Y Chan; Curtis D Klaassen; José E Manautou
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  Mechanisms regulating human FMO3 transcription.

Authors:  David E Klick; Ronald N Hines
Journal:  Drug Metab Rev       Date:  2007       Impact factor: 4.518

4.  Flavin-containing monooxygenase-3: induction by 3-methylcholanthrene and complex regulation by xenobiotic chemicals in hepatoma cells and mouse liver.

Authors:  Trine Celius; Andrea Pansoy; Jason Matthews; Allan B Okey; Marilyn C Henderson; Sharon K Krueger; David E Williams
Journal:  Toxicol Appl Pharmacol       Date:  2010-06-04       Impact factor: 4.219

5.  High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes.

Authors:  A Enomoto; K Itoh; E Nagayoshi; J Haruta; T Kimura; T O'Connor; T Harada; M Yamamoto
Journal:  Toxicol Sci       Date:  2001-01       Impact factor: 4.849

6.  Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1alpha and Nrf2 to attenuate inflammatory cytokine expression.

Authors:  Samantha M Yeligar; Keigo Machida; Vijay K Kalra
Journal:  J Biol Chem       Date:  2010-09-10       Impact factor: 5.157

Review 7.  Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease.

Authors:  Lauren M Aleksunes; José E Manautou
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

8.  Complex mechanism underlying transcriptional control of the haplotyped flavin-containing monooxygenase 3 (FMO3) gene in Japanese: different regulation between mutations in 5'-upstream distal region and common element in proximal region.

Authors:  Makiko Shimizu; Norie Murayama; Satomi Nagashima; Masaki Fujieda; Hiroshi Yamazaki
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

9.  Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.

Authors:  David E Klick; Jeff D Shadley; Ronald N Hines
Journal:  Biochem Pharmacol       Date:  2008-05-07       Impact factor: 5.858

10.  Induction of Mrp3 and Mrp4 transporters during acetaminophen hepatotoxicity is dependent on Nrf2.

Authors:  Lauren M Aleksunes; Angela L Slitt; Jonathan M Maher; Lisa M Augustine; Michael J Goedken; Jefferson Y Chan; Nathan J Cherrington; Curtis D Klaassen; José E Manautou
Journal:  Toxicol Appl Pharmacol       Date:  2007-08-31       Impact factor: 4.219

View more
  1 in total

Review 1.  From hepatoprotection models to new therapeutic modalities for treating liver diseases: a personal perspective.

Authors:  Swetha Rudraiah; José E Manautou
Journal:  F1000Res       Date:  2016-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.